156 related articles for article (PubMed ID: 20053769)
1. Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity.
Chua YS; Chua YL; Hagen T
Mol Cancer Ther; 2010 Jan; 9(1):224-35. PubMed ID: 20053769
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol.
Hagen T; D'Amico G; Quintero M; Palacios-Callender M; Hollis V; Lam F; Moncada S
Biochem Biophys Res Commun; 2004 Sep; 322(3):923-9. PubMed ID: 15336552
[TBL] [Abstract][Full Text] [Related]
3. Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.
LaVallee TM; Burke PA; Swartz GM; Hamel E; Agoston GE; Shah J; Suwandi L; Hanson AD; Fogler WE; Sidor CF; Treston AM
Mol Cancer Ther; 2008 Jun; 7(6):1472-82. PubMed ID: 18566218
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of 2-methoxyestradiol: new developments.
Mooberry SL
Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
[TBL] [Abstract][Full Text] [Related]
6. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
Mabjeesh NJ; Escuin D; LaVallee TM; Pribluda VS; Swartz GM; Johnson MS; Willard MT; Zhong H; Simons JW; Giannakakou P
Cancer Cell; 2003 Apr; 3(4):363-75. PubMed ID: 12726862
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.
Zhe N; Chen S; Zhou Z; Liu P; Lin X; Yu M; Cheng B; Zhang Y; Wang J
Cancer Biol Ther; 2016 Jun; 17(6):625-34. PubMed ID: 27082496
[TBL] [Abstract][Full Text] [Related]
8. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
Mooberry SL
Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
[TBL] [Abstract][Full Text] [Related]
9. Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines.
Visagie M; Theron A; Mqoco T; Vieira W; Prudent R; Martinez A; Lafanechère L; Joubert A
PLoS One; 2013; 8(9):e71935. PubMed ID: 24039728
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
11. Anticancer drug 2-methoxyestradiol protects against renal ischemia/reperfusion injury by reducing inflammatory cytokines expression.
Chen YY; Yeh CH; So EC; Sun DP; Wang LY; Hsing CH
Biomed Res Int; 2014; 2014():431524. PubMed ID: 25229058
[TBL] [Abstract][Full Text] [Related]
12. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
[TBL] [Abstract][Full Text] [Related]
13. 2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma.
Lin H; Jiang X; Zhu H; Jiang W; Dong X; Qiao H; Sun X; Jiang H
Tumour Biol; 2016 Jan; 37(1):381-91. PubMed ID: 26219898
[TBL] [Abstract][Full Text] [Related]
14. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
Escuin D; Kline ER; Giannakakou P
Cancer Res; 2005 Oct; 65(19):9021-8. PubMed ID: 16204076
[TBL] [Abstract][Full Text] [Related]
15. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice.
Schaible EV; Windschügl J; Bobkiewicz W; Kaburov Y; Dangel L; Krämer T; Huang C; Sebastiani A; Luh C; Werner C; Engelhard K; Thal SC; Schäfer MK
J Neurochem; 2014 Jun; 129(6):940-54. PubMed ID: 24606183
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS
Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471
[TBL] [Abstract][Full Text] [Related]
17. PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression.
Muh CR; Joshi S; Singh AR; Kesari S; Durden DL; Makale MT
J Neurooncol; 2014 Jan; 116(1):89-97. PubMed ID: 24162827
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of 2-methoxyestradiol-induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
Mabjeesh NJ; Shefler A; Amir S; Matzkin H
Prostate; 2008 May; 68(6):679-89. PubMed ID: 18288682
[TBL] [Abstract][Full Text] [Related]
19. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2.
Bu SZ; Huang Q; Jiang YM; Min HB; Hou Y; Guo ZY; Wei JF; Wang JW; Ni X; Zheng SS
Apoptosis; 2006 Mar; 11(3):413-25. PubMed ID: 16538384
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
